Keynote speaker
Director, Madrigal Pharmaceuticals
Rebecca Taub, Director at Madrigal Pharmaceuticals, appears in the programmes of 2 conferences on kongre.net, once as a keynote speaker. Next: 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026).
1–3 Dec 2026Boston, United States of America
15–17 Sept 2026Boston, United States of America
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical
Principal Scientist II, Novartis AG
CMO, Mediar Therapeutics
Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals
Head of Translational Sciences, Fibrocor Therapeutics
Medical Director, Takeda Pharmaceutical
Senior Director, Cellarity
Chief Executive Officer, Cirius Therapeutics
Faculty, Harvard Medical School and Mass General Brigham
Associate Director, Clinical Research, Akero Therapeutics
Vice President, Discovery Biology, Sepia Therapeutics
Scientific Director & Associate Research Fellow, Pfizer
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Rebecca Taub, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].